Point72 Middle East Fze Dexcom Inc Put Options Transaction History

Point72 Middle East Fze

  • $0
  • Q3 2024

Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$75.49 - $124.16 $188,725 - $310,400
-2,500 Reduced 32.47%
5,200 $645,000
Q3 2023

Nov 14, 2023
BUY
$86.06 - $137.93 $430,300 - $689,650
5,000 Added 185.19%
7,700 $718,000
Q2 2023

Aug 14, 2023
BUY
$112.47 - $130.98 $168,705 - $196,469
1,500 Added 125.0%
2,700 $346,000
Q1 2023

May 15, 2023
SELL
$104.0 - $122.92 $312,000 - $368,760
-3,000 Reduced 71.43%
1,200 $139,000
Q4 2022

Feb 14, 2023
BUY
$84.98 - $122.67 $356,916 - $515,214
4,200 New
4,200 $0

Others Institutions Holding DXCM

# of Institutions
1,014
Shares Held
351M
Call Options Held
5.51M
Put Options Held
5.6M
View Full List

About DEXCOM INC

DXCM Quotes by TradingView
  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Point72 Middle East Fze Portfolio

Follow Point72 Middle East Fze and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Middle East Fze, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Middle East Fze with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email